Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | MTRIInMed Pharmaceuticals Inc.FY2025 · Jun |
|---|---|
| Revenue | $4.94M |
| Revenue, yoy | +7.5% |
| Net income | $12.56M |
| Net income, yoy | −638.9% |
| Net margin | — |
| Free cash flow | $7.00M |
| FCF margin | — |
| EPS, diluted | $3.12 |
Add another company.